Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (121-130 of 313) with videos related to

Pageof 32
Sort By:
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|March 15, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet NeedsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Chemotherapy|August 16, 2017
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic TransplantAnnamaria Petrungaro, Massimo Gentile, Carla Mazzone, et al.
European Journal of Haematology|April 2, 2026
Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical TranslationAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational OpportunitiesMaria Eugenia Alvaro, Santino Caserta, Enrica Antonia Martino, et al.
European Journal of Haematology|March 18, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging PerspectivesMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Chemotherapy|July 26, 2017
Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with DasatinibErnesto Vigna, Bruno Martino, Francesco Bacci, et al.
Cells|January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?Paola Menichini, Paola Monti, Andrea Speciale, et al.
Pageof 32

Showing results (121-130 of 313) with videos related to

Sort By:
Pageof 32
Clinical and Translational Medicine|March 7, 2026
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapyEnrica Antonia Martino, Santino Caserta, Mamdouh Skafi, et al.
European Journal of Haematology|March 15, 2026
Ph-Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet NeedsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Cells|July 13, 2026
Ferroptosis in Lymphoproliferative DisordersSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Chemotherapy|August 16, 2017
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic TransplantAnnamaria Petrungaro, Massimo Gentile, Carla Mazzone, et al.
European Journal of Haematology|April 2, 2026
Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical TranslationAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
Antibiotics (Basel, Switzerland)|April 27, 2026
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational OpportunitiesMaria Eugenia Alvaro, Santino Caserta, Enrica Antonia Martino, et al.
European Journal of Haematology|March 18, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging PerspectivesMaria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, et al.
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Chemotherapy|July 26, 2017
Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with DasatinibErnesto Vigna, Bruno Martino, Francesco Bacci, et al.
Cells|January 12, 2021
Antitumor Effects of PRIMA-1 and PRIMA-1<sup>Met</sup> (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?Paola Menichini, Paola Monti, Andrea Speciale, et al.
Pageof 32